Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.

Raji, Yemi R; Ajayi, Samuel O; Adeoye, Abiodun M; Amodu, Olukemi; Tayo, Bamidele O; Salako, Babatunde L

Raji, Yemi R; Ajayi, Samuel O; Adeoye, Abiodun M; Amodu, Olukemi; Tayo, Bamidele O; Salako, Babatunde L.

Raji YR; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ajayi SO; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adeoye AM; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Amodu O; Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Tayo BO; Department of Public Health Sciences, Loyola University Chicago, Maywood, Illinois.
Salako BL; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Afr Health Sci ; 22(1): 344-351, 2022 Mar.

Article en En | MEDLINE | ID: mdl-36032486

Asunto(s)

Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica; Insuficiencia Renal Crónica; Adulto; Anciano; Biomarcadores; Estudios Transversales; Femenino; Factor-23 de Crecimiento de Fibroblastos; Factores de Crecimiento de Fibroblastos; Humanos; Masculino; Persona de Mediana Edad; Minerales; Nigeria; Hormona Paratiroidea

Palabras clave

CKD; FGF 23; diagnostic; mineral bone disease; parathyroid hormone

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica / Insuficiencia Renal Crónica Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Africa Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google